Details

Autor(en) / Beteiligte

• Culman, J
• Blume, A
• Gohlke, P
• Unger, T

Titel

The renin-angiotensin system in the brain: possible therapeutic implications for AT sub(1)-receptor blockers

Ist Teil von

• Journal of human hypertension, 2002-08, Vol.16 (S3), p.S64-S70

Erscheinungsjahr

2002

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Biochemical, physiological and functional studies suggest that the brain renin-angiotensin system (RAS) is regulated independently of the peripheral RAS. The classical actions of angiotensin II in the brain include blood pressure control, drinking behaviour, natriuresis and the release of vasopressin into the circulation. At least two subtypes of G-protein coupled receptors, the AT sub(1) and the AT sub(2) receptor, have been identified. Most of the classic actions of angiotensin II in the brain are mediated by AT sub(1) receptors. The AT sub(2) receptor is involved in brain development and neuronal regeneration and protection. Additionally, AT sub(2) receptors can modulate some of the classic angiotensin II actions in the brain. Selective non-peptide AT sub(1) receptor blockers, applied systemically, have been shown to inhibit both peripheral and brain AT sub(1)receptors. In genetically hypertensive rats, inhibition of brain AT sub(1) receptors may contribute to the blood pressure lowering effects of AT sub(1) receptor blockers. Animal studies have shown that AT sub(1) receptor antagonists enable endogenous angiotensin II to stimulate neuronal regeneration via activation of AT sub(2) receptors. In animal models, inhibition of the brain RAS proved to be beneficial with respect to stroke incidence and outcome. Blockade of brain and cerebrovascular AT sub(1) receptors by AT sub(1) receptor blockers prevents the reduction in blood flow during brain ischaemia, reduces the volume of ischaemic injury and improves neurological outcome after brain ischaemia. This paper reviews the actions of angiotensin II and its receptors in the brain, and discusses the possible consequences of AT sub(1) receptor blockade in neuroprotection, neuroregeneration, cerebral haemodynamics and ischaemia.JOURNAL OF HUMAN HYPERTENSION: (2002) 16, S64-S70. doi:10.1038/sj.jhh.1001442